However, cyclin E2 modulation does not always lead to changes in cyclin E1 expression, for example in smooth muscle cells the cyclin E2 siRNA treatment leads to downregulation of cyclin E1 [82], and cyclin E1 and E2 are co-expressed in other tissues [5,45], and in some tumours [83]. The gene discussed is CCNE2; the disease is neoplasm.